Event Preview | Join EClinCloud at "DCT Practice in China: Visiting Pfizer"

Source: EClinCloud.
To promote compliant practice and innovative development in decentralized clinical trials (DCT) and improve clinical trial efficiency and quality, the CMAC DCT Alliance launched the "DCT Practice in China: Visiting Well-Known Pharmaceutical Companies" event series.
As a promoter of digital clinical trials in China, EClinCloud has remained dedicated to the research and development of decentralized and intelligent clinical technologies, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, reduce clinical research costs and risks, and accelerate new drug launches. In March 2023, leveraging its advanced eCOA system along with its professional medical team and services, EClinCloud supported the regulatory approval and market launch of Raynovent's COVID-19 therapeutic drug.
For this event, Dr. Qin Long, Founder and CEO of EClinCloud, has been invited to attend "DCT Practice in China: Visiting Pfizer" on August 31, where he will share insights on how EClinCloud's eCOA system supported the rapid approval of a new COVID-19 drug and discuss core DCT clinical model application scenarios and compliant practices.
Presentation Details
Date & Time
August 31, 2023, 14:10–14:25
Location
Building 3, Lianhua Business Park, 60 Naxian Road, Pudong New Area, Shanghai
Presentation
Topic
Practice in Action: How EClinCloud's eCOA System Supported the Rapid Approval of a New COVID-19 Drug

Dr. Qin Long
Founder and CEO, EClinCloud
- Over 17 years of experience in technology applications within the clinical research industry;
- An innovative and inspiring leader, and a pioneer in promoting and implementing eCOA, EDC, CTMS, and related technology solutions in clinical trial research in China;
- Previously served as Asia-Pacific head for several international technology companies, leading rapid regional business growth;
- An entrepreneur driven by academia and science, dedicated with great passion to shaping new models for future clinical trials.

EClinCloud is a technology company focused on clinical R&D, providing an integrated, interoperable, all-in-one cloud platform for clinical trials (including solutions such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis across various technology products and solutions including eCOA, CTMS, eTMF, EDC, RTSM, and RM) as well as clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system, ophthalmology, and others). Combining cutting-edge technology with life data, it is building a globally leading, patient-centric SaaS cloud platform for clinical evidence support, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



